Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu Sun

Showing results (231-240 of 338) with videos related to

Pageof 34
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 9, 2018
Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical PracticeSehhoon Park, Beung-Chul Ahn, Sung Won Lim, et al.
Cancer Chemotherapy and Pharmacology|July 5, 2012
Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutationSu-Hee Cho, Lee Chun Park, Jun Ho Ji, et al.
Cancer Medicine|December 1, 2022
Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinomaSehhoon Park, Hongui Cha, Hong Sook Kim, et al.
Oncology|September 22, 2011
Patterns of skin and soft tissue metastases from breast cancer according to subtypes: relationship between EGFR overexpression and skin manifestationsJee Hyun Kong, Yeon Hee Park, Jung A Kim, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
CXCL1 Triggers Caspase-3 Dependent Tau Cleavage in Long-Term Neuronal Cultures and in the Hippocampus of Aged Mice: Implications in Alzheimer's DiseaseXiao-Fang Zhang, Yan-Feng Zhao, Shun-Wei Zhu, et al.
BMC Ophthalmology|January 11, 2020
Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitorsEunhae Shin, Dong Hui Lim, Jisang Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2023
Programmed Death-Ligand 1 Copy Number Alteration as an Adjunct Biomarker of Response to Immunotherapy in Advanced NSCLCTae Hee Hong, Yeong Hak Bang, Cheol Yong Joe, et al.
Translational Lung Cancer Research|March 18, 2024
Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analysesSehhoon Park, Jun-Kyu Kang, Naeun Lee, et al.
Cancer Chemotherapy and Pharmacology|April 24, 2015
A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation testMoon Ki Choi, Jung Yong Hong, Won Jin Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trialSung Won Lim, Sehhoon Park, Youjin Kim, et al.
Pageof 34

Showing results (231-240 of 338) with videos related to

Sort By:
Pageof 34
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 9, 2018
Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical PracticeSehhoon Park, Beung-Chul Ahn, Sung Won Lim, et al.
Cancer Chemotherapy and Pharmacology|July 5, 2012
Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutationSu-Hee Cho, Lee Chun Park, Jun Ho Ji, et al.
Cancer Medicine|December 1, 2022
Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinomaSehhoon Park, Hongui Cha, Hong Sook Kim, et al.
Oncology|September 22, 2011
Patterns of skin and soft tissue metastases from breast cancer according to subtypes: relationship between EGFR overexpression and skin manifestationsJee Hyun Kong, Yeon Hee Park, Jung A Kim, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
CXCL1 Triggers Caspase-3 Dependent Tau Cleavage in Long-Term Neuronal Cultures and in the Hippocampus of Aged Mice: Implications in Alzheimer's DiseaseXiao-Fang Zhang, Yan-Feng Zhao, Shun-Wei Zhu, et al.
BMC Ophthalmology|January 11, 2020
Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitorsEunhae Shin, Dong Hui Lim, Jisang Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2023
Programmed Death-Ligand 1 Copy Number Alteration as an Adjunct Biomarker of Response to Immunotherapy in Advanced NSCLCTae Hee Hong, Yeong Hak Bang, Cheol Yong Joe, et al.
Translational Lung Cancer Research|March 18, 2024
Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analysesSehhoon Park, Jun-Kyu Kang, Naeun Lee, et al.
Cancer Chemotherapy and Pharmacology|April 24, 2015
A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation testMoon Ki Choi, Jung Yong Hong, Won Jin Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trialSung Won Lim, Sehhoon Park, Youjin Kim, et al.
Pageof 34